Hormones and hemodynamics in heart failure.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  New England Journal of Medicine

• Publication date

  1999-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1056/NEJM199908193410806PMID 10451464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Biochemical detection of left-ventricular systolic dysfunction.

  1998cited by this paper
• Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

  1998cited by this paper
• Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.

  1997cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.

  1996cited by this paper
• Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.

  1996cited by this paper
• Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis

  1995cited by this paper
• Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane.

  1995cited by this paper
• REPEATED ADMINISTRATION OF A F(ab′)2 FRAGMENT OF AN ANTI‐TUMOR NECROSIS FACTOR α MONOCLONAL ANTIBODY IN PATIENTS WITH SEVERE SEPSIS: EFFECTS ON THE CARDIOVASCULAR SYSTEM AND CYTOKINE LEVELS

  1994cited by this paper
• Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.

  1994cited by this paper
• Cloning of the Human Type‐2 Vasopressin Receptor Gene

  1993cited by this paper
• The L-arginine-nitric oxide pathway.

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

  1993cited by this paper
• Glomerular effects of angiotensin II: a reappraisal based on studies with non-peptide receptor antagonists.

  1993cited by this paper
• Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure.

  1992cited by this paper
• Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• A Unifying Hypothesis of Body Fluid Volume Regulation

  1992cited by this paper
• Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.

  1992cited by this paper
• Morphometry of Human Coronary Capillaries During Normal Growth and the Effect of Age in Left Ventricular Pressure‐Overload Hypertrophy

  1992cited by this paper
• Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.

  1991cited by this paper
• Pathogenesis of ascites formation : mechanism of impaired aldosterone escape in cirrhosis

  1991cited by this paper
• Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody.

  1990cited by this paper
• Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.

  1990cited by this paper
• Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

  1990cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Body fluid volume regulation in health and disease: a unifying hypothesis.

  1990cited by this paper
• Enzymatic and binding effects of atrial natriuretic factor in glomeruli and nephrons.

  1989cited by this paper
• Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II.

  1989cited by this paper
• Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure.

  1989cited by this paper
• Effects of Incremental Infusions of Atrial Natriuretic Factor on Aldosterone, Renin, and Blood Pressure in Humans

  1988cited by this paper
• Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)

  1988cited by this paper
• Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

  1988cited by this paper
• Neural control of renal function in edema-forming states.

  1988cited by this paper
• Atrial natriuretic polypeptide (ANP) in human ventricle. Increased gene expression of ANP in dilated cardiomyopathy.

  1987cited by this paper
• Renal and Systemic Hemodynamic Effects of Synthetic Atrial Natriuretic Peptide in the Anesthetized Rat

  1986cited by this paper
• Role of Vasopressin in Experimental Congestive Cardiac Failure

  1986cited by this paper
• Effect of vasopressin antagonist on water excretion in inferior vena cava constriction.

  1986cited by this paper
• Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

  1986cited by this paper
• Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.

  1986cited by this paper
• Angiotensin II-induced thirst and vasopressin release in man.

  1985cited by this paper
• Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

  1984cited by this paper
• Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

  1982cited by this paper
• Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure.

  1981cited by this paper
• Effects of renal nerve stimulation, norepinephrine and angiotensin II on renal blood flow in relation to release of PG-like substances in anesthetized dogs.

  1981cited by this paper
• Osmotic and nonosmotic control of vasopressin release.

  1979cited by this paper
• Acute oliguric renal failure induced by indomethacin: possible mechanism.

  1979cited by this paper
• Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption.

  1976cited by this paper
• Effects of Norepinephrine and Angiotensin II on the Determinants of Glomerular Ultrafiltration and Proximal Tubule Fluid Reabsorption in the Rat

  1975cited by this paper
• Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion.

  1973cited by this paper
• Contribution of Baroreceptors to the Control of Renal Function

  1964cited by this paper
• The effect of negative pressure breathing on urine flow.

  1954cited by this paper

• Remote Patient Care of Patients with Heart Failure A Focused Review on the HearLogic-System.

  2026cites this paper
• Hyponatraemia in heart failure: a mechanistic approach to contemporary management

  2026cites this paper
• Real-world analysis of healthcare utilization with baroreflex activation therapy for heart failure.

  2025cites this paper
• Counteraction of the Natriuretic Peptide and the Renin-Angiotensin-Aldosterone Systems in Acute Heart Failure

  2025cites this paper
• Inter‐organ crosstalk: The kidney's role in systemic health and disease

  2025cites this paper
• Exploring the Utility of Renal Resistive Index in Critical Care: Insights into ARDS and Cardiac Failure

  2025cites this paper
• Renal Resistive Index in Cardiac Surgery: A Narrative Review

  2025cites this paper
• Impact of early initiation of renal replacement therapy in patients on venoarterial ECMO using target trial emulation with Japanese nationwide data

  2025cites this paper
• Efficacy and safety of combining a thiazide diuretic with a loop diuretic in decompensated heart failure: A systematic review and meta-analysis

  2025cites this paper
• Decline in glomerular filtration rate as an endpoint in heart failure clinical trials: challenges and solutions.

  2025cites this paper
• The Effects of the Natriuretic Peptide System on Alveolar Epithelium in Heart Failure

  2025cites this paper
• Impact of hypotonic hyponatremia on outcomes in patients undergoing transcatheter aortic valve replacement: a national inpatient sample

  2025cites this paper
• Renal Macro- and Microcirculatory Perturbations in Acute Kidney Injury and Chronic Kidney Disease Associated with Heart Failure and Cardiac Surgery.

  2025cites this paper
• Efeitos do Sódio na Pressão Capilar Pulmonar em Pacientes com Insuficiência Cardíaca Compensada durante 12 Meses de Acompanhamento: Um Estudo Randomizado e Duplo-Cego

  2025cites this paper
• Blood urea nitrogen to left ventricular ejection fraction ratio is a predictor of in-hospital outcomes in ST-elevation myocardial infarction patients: a case control study

  2025cites this paper
• Novel therapeutic targets for cardiorenal syndrome.

  2025cites this paper
• Hormonal crossroads of the heart: from classic endocrine regulation to cardiac hormone secretion: an updated review.

  2025cites this paper
• Genotype-phenotype insights of pediatric dilated cardiomyopathy

  2025cites this paper
• Effect of Angiotensin Receptor-Neprilysin Inhibitor in Patients With Heart Failure: A Real-World Study

  2025cites this paper
• The addition of alpha-ketoglutarate to NT-proBNP improves the prediction of long-term all-cause mortality in acute heart failure patients

  2025cites this paper
• Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?

  2025cites this paper
• Explainable machine learning framework using visceral adiposity index to predict cardiorenal syndrome: a survey-weighted NHANES study with SHAP interpretation

  2025cites this paper
• Effects of high-dose alacepril on the renin-angiotensin-aldosterone system and autonomic nervous system function in healthy dogs

  2025cites this paper
• Sodium Effects on Pulmonary Capillary Wedge Pressure in Compensated Heart Failure Patients During 12 Months of Follow-Up: A Randomized and Double-Masked Study

  2025cites this paper
• How to Enhance Cardiorenal Benefits in Patients With Chronic Heart Failure?

  2025cites this paper
• Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome.

  2025cites this paper
• Vibrational Spectra, molecular structure, electronic, pharmaceutical and bonding nature of (4S)-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline-7,8-diol - Anti hypertension agent

  2024cites this paper
• Cardiac Surgery–Associated Acute Kidney Injury

  2024cites this paper
• Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction

  2024cites this paper
• Neurohormonal activation pattern in patients with atrial septal defect

  2024cites this paper
• Adequacy of Ambulatory Hemodynamic Assessments for Reducing All-Cause Mortality in Individuals With Heart Failure

  2024cites this paper
• The Effect of Tolvaptan on Metabolism and Electrolyte Homeostasis in Patients with Heart Failure: A Systematic Review and Meta-Analysis

  2024cites this paper
• Towards etiological treatments in cardiomyopathies.

  2024cites this paper
• Neurohormonal Activation and Renal Chloride Avidity in Acute Heart Failure: Clinical Evidence Supporting the “Chloride Theory”

  2024cites this paper
• Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.

  2024cites this paper
• Effect of Post-Loop Diuretic Urinary Sodium Level on Length of Stay and Rehospitalization in Acutely Decompensated Heart Failure Patients

  2024cites this paper
• Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond

  2024influential citation
• Full Decongestion in Acute Heart Failure Therapy.

  2024cites this paper
• Prognostic impact of beta‐blocker use by N‐terminal pro‐brain natriuretic peptide level in acute heart failure patients

  2024cites this paper
• Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First‐in‐Human, Randomized, Single‐Blind, Placebo‐Controlled Study

  2024cites this paper
• The role of urine chloride in acute heart failure

  2024cites this paper
• Cardiorenal syndrome: Plasmonic biosensors.

  2024cites this paper
• Inhibition of myeloperoxidase to treat left ventricular dysfunction in non‐ischaemic cardiomyopathy

  2024cites this paper
• Blood Urea Nitrogen to Left Ventricular Ejection Ratio as a Predictor of Short-Term Outcome in Acute Myocardial Infarction Complicated by Cardiogenic Shock

  2024cites this paper
• Ondansetron use is associated with increased risk of acute kidney injury in ICU patients following cardiac surgery: a retrospective cohort study

  2024cites this paper
• Cardio-Renal Syndrome: Latest Developments in Device-Based Therapy

  2024cites this paper
• Captopril to Lisinopril Conversion in Pediatric Cardiothoracic Surgery Patients Less Than 7 Years of Age (RISE-7)

  2023cites this paper
• Perirenal Fat and Kidney Function Deterioration in Patients With Acute Decompensated Heart Failure

  2023cites this paper
• The Importance of Optimal Hydration in Patients with Heart Failure—Not Always Too Much Fluid

  2023cites this paper
• Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?

  2023cites this paper
• Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story

  2023cites this paper
• Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy

  2023cites this paper
• Hyponatremia Associated with Congestive Heart Failure: Involvement of Vasopressin and Efficacy of Vasopressin Receptor Antagonists

  2023cites this paper
• Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure

  2023cites this paper
• Cardiovascular Consequences of Acute Kidney Injury: Treatment Options

  2023cites this paper
• Heart Failure Remote Monitoring: A Review and Implementation How-To

  2023cites this paper
• The Cardiorenal Syndrome in Heart Failure

  2023cites this paper
• Comparative observation of changes in natriuretic peptides before and after interventional therapy for congenital heart disease

  2023cites this paper
• Diagnosis and Management of Malnutrition in Patients with Heart Failure

  2023cites this paper
• Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy.

  2023cites this paper
• How should we treat acute kidney injury caused by renal congestion?

  2023cites this paper
• Falling corin and ANP activity levels accelerate development of heart failure and cardiac fibrosis

  2023cites this paper
• Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status

  2023influential citation
• A Role of Sodium-Glucose Co-Transporter 2 in Cardiorenal Anemia Iron Deficiency Syndrome

  2023cites this paper
• Acute Cardiorenal Syndrome: An Update

  2023cites this paper
• Hyponatremia and lower normal serum sodium levels are associated with an increased risk of all‐cause death in heart failure patients

  2023cites this paper
• Association of hyponatremia with clinical outcomes in patients admitted with acute pulmonary embolism

  2023cites this paper
• The role of comorbidities in acute heart failure outcomes.

  2023cites this paper
• FEATURES OF PERIOPERATIVE MANAGEMENT OF PEDIATRIC PATIENTS WITH CONGENITAL HEART DEFECTS

  2023cites this paper
• The combined impact of hyponatremia and hematocrit on the risk for 90-day readmission and death in patients with heart failure: dilutional hyponatremia versus depletional hyponatremia

  2023cites this paper
• Twenty-four hour ambulatory blood pressure monitoring in patients with stable heart failure. Prevalence and associated factors.

  2023cites this paper
• Plasma renin activity variation following admission predicts patient outcome in acute decompensated heart failure with reduced and mildly reduced ejection fraction

  2023cites this paper
• Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.

  2023cites this paper
• Relationship between serum sodium levels and all-cause mortality in congestive heart failure patients: A retrospective cohort study based on the Mimic-III database

  2023cites this paper
• Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review

  2023cites this paper
• Pathophysiology-Based Management of Acute Heart Failure

  2023cites this paper
• Impact of Renal Congestion in Patients With Secondary Mitral Regurgitation After Mitral Transcatheter Edge-to-Edge Repair.

  2023cites this paper
• Interpreting Estimated GFR Variability and Its Clinical Significance

  2023cites this paper
• Right Heart Function in Cardiorenal Syndrome

  2022cites this paper
• Edema formation in congestive heart failure and the underlying mechanisms

  2022cites this paper
• Does Hyponatremia Affect the Short-Term Outcomes of Colorectal Cancer Surgery: A Propensity Score Matching Analysis

  2022cites this paper
• Skeletal muscle mitochondrial remodeling in heart failure: An update on mechanisms and therapeutic opportunities.

  2022cites this paper
• Renal Replacement Therapy in Patients With Acute Decompensated Pulmonary Hypertension Admitted to the Intensive Care Unit

  2022cites this paper
• Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism

  2022cites this paper
• Renal Dysfunction in Patients with Left Ventricular Assist Device

  2022cites this paper
• High nocturnal periodic breathing reported by PAP adherence data predicts decompensation of heart failure

  2022cites this paper
• Reporting and Definition of Kidney Death in Heart Failure Clinical Trials.

  2022cites this paper
• The Impact of Cardio Renal Syndrome (CRS) in Renal Transplant Recipients: A Systematic Review

  2022cites this paper
• Suppression of Cardiogenic Edema with Sodium–Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Insights from Pre-Clinical Studies

  2022cites this paper
• Preoperative Evaluation and Care of Heart Transplant Candidates.

  2022cites this paper
• Soluble (Pro)Renin Receptor Levels Are Regulated by Plasma Renin Activity and Correlated with Edema in Mice and Humans with HFrEF

  2022cites this paper
• Mechanistic Insights in Cardiorenal Syndrome.

  2022cites this paper
• Future scope and challenges for congestive heart failure: Moving towards development of pharmacotherapy.

  2022cites this paper
• Monitoring of Kidney Fibrosis Changes in Patients with Chronic Heart Failure

  2022cites this paper
• Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future

  2022cites this paper
• Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure

  2022cites this paper
• Dysnatremia in Gastrointestinal Disorders

  2022cites this paper
• Medical Management of Patients With Heart Failure and Reduced Ejection Fraction

  2022cites this paper
• Long-term evolution of N-terminal pro-brain natriuretic peptide levels and exercise capacity in 132 left ventricular assist device recipients.

  2022cites this paper
• Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients

  2022cites this paper